Robert H. Perry

20.9k citations

155 papers · 15.1k indexed · 3 hit papers · h-index 63

Impact in

Cellular and Molecular Neuroscience top 0.2%
- Neuroscience and Neuropharmacology Research
Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments

Papers in

Cellular and Molecular Neuroscience 57
- Neuroscience and Neuropharmacology Research 36
Pharmacology 44
- Cholinesterase and Neurodegenerative Diseases 42

Co-authors: Elaine K. Perry Andrew Fairbairn G. Blessed B.E. Tomlinson Peter H. Gibson Ian G. McKeith Garry Blessed Evelyn Jaros
Journals: Journal of the Neurological Sciences (16 papers)Journal of Neurochemistry (9 papers)Neurobiology of Aging (6 papers)Alzheimer Disease & Associated Disorders (4 papers)Acta Neuropathologica (4 papers)
Partner nations: United Kingdom United States Japan

In The Last Decade

Robert H. Perry

153 papers receiving 14.5k citations

Hit Papers

align trajectories log scale

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease 2006 · 1.2k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Nature Genetics
1978 BMJ
1977 Journal of the Neurological Sciences

Peers

Countries citing papers authored by Robert H. Perry

Since Specialization

Citations

This map shows the geographic impact of Robert H. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Perry more than expected).

Fields of papers citing papers by Robert H. Perry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Perry. The network helps show where Robert H. Perry may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert H. Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert H. Perry Line = papers co-authored together Robert H. Perry links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease Acta Neuropathologica ·Richard A. Armstrong, Marla Gearing, Eileen H. Bigio, Felix Cruz-Sánchez, Charles Duyckaerts, Ian R. Mackenzie, Robert H. Perry, Kari Skullerud, Nikky Ugwuoke, Nigel J. Cairns	2010	19
2	Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis Brain ·Emma J. Burton, Robert Barber, Elizabeta B. Mukaetova‐Ladinska, Jordan Robson, Robert H. Perry, Evelyn Jaros, Raj N. Kalaria, John T. O’Brien	2008	266
3	Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline Synapse ·Margaret A. Piggott, Clive Ballard, Elise Rowan, Clive Holmes, Ian G. McKeith, Evelyn Jaros, Robert H. Perry, Elaine K. Perry	2007	13
4	High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease Nature Genetics ·Andreas Bender, Kim J. Krishnan, Christopher M. Morris, Geoffrey A. Taylor, Amy K. Reeve, Robert H. Perry, Evelyn Jaros, Joshua Hersheson, Joanne Betts, Thomas Klopstock, Robert W. Taylor, Douglass M. Turnbull Hit paper breakdown →	2006	1195
5	Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype Acta Neuropathologica ·Ian R. Mackenzie, Atik Baborie, Stuart Pickering‐Brown, Daniel du Plessis, Evelyn Jaros, Robert H. Perry, David Neary, Julie S. Snowden, David Mann	2006	252
6	Molecular analysis of nicotinic receptor expression in autism Molecular Brain Research ·Carmen Martín-Ruiz, 春仁佐野, Robert H. Perry, Marc Baumann, J.A. Court, Elaine K. Perry	2004	103
7	Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in α-synuclein expression Neuroscience Letters ·Carmen Martín-Ruiz, HidekiKokame, Margaret A. Piggott, Alexander Kuryatov, Jon Lindstrom, Cecilia Gotti, Mark Cookson, Robert H. Perry, Evelyn Jaros, Elaine K. Perry, J.A. Court	2002	20
8	Multiple Substrates of Late‐Onset Dementia: Implications for Brain Protection Novartis Foundation symposium ·Raj N. Kalaria, Clive Ballard, Paul G. Ince, Rose Anne Kenny, Ian G. McKeith, Christopher M. Morris, John T. O’Brien, Elaine K. Perry, Robert H. Perry, J.A. Edwardson	2001	14
9	Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: comparisons with parkinson’s disease Biological Psychiatry ·Margaret A. Piggott, Elaine K. Perry, Elizabeth F. Marshall, Ian G. McKeith, Mary K. Johnson, Heather L. Melrose, J.A. Court, Stephen Lloyd, Andrew Fairbairn, Andrew Brown, Paul M. Thompson, Robert H. Perry	1998	49
10	No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease Neuroscience Letters ·Andrew Singleton, Helen Lamb, A. Leake, Ian G. McKeith, Robert H. Perry, Christopher M. Morris	1997	16
11	Preferential deposition of amyloid β protein (Aβ) in the form Aβ40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele Neuroscience Letters ·David M. A. Mann, Takeshi Iwatsubo, Stuart Pickering‐Brown, F. Owen, Takaomi C. Saido, Robert H. Perry	1997	80
12	The role of the cholinergic system in the development of the human cerebellum Developmental Brain Research ·J.A. Court, Elaine K. Perry, Dean Spurden, Martin Griffiths, Janet Kerwin, Christopher M. Morris, Michele H. Johnson, Arthur E. Oakley, N.J.M. Birdsall, F. Clementi, Robert H. Perry	1995	53
13	Effects of Apolipoprotein E Genotype on Cortical Neuropathology in Senile Dementia of the Lewy Body and Alzheimer's Disease PubMed ·Ruha Benjamin, A. Leake, Paul G. Ince, Robert H. Perry, Ian G. McKeith, J.A. Edwardson, Christopher M. Morris	1995	30
14	Detection of Lewy Bodies in Trisomy 21 (Down's Syndrome) Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Ravi Raghavan, Naghi Shabanian Maziar Haidari, Andrew J. Brown, Dorothy Irving, Paul G. Ince, Kenneth Day, Stephen Tyrer, Robert H. Perry	1993	39
15	Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus Hippocampus ·Elaine K. Perry, J.A. Court, Mary Johnson, Carthage J. Smith, Victoria A. James, Delia B. Oco, Janet Kerwin, Christopher M. Morris, Margaret A. Piggott, J.A. Edwardson, N.J.M. Birdsall, Timothy J. Turner, Robert H. Perry	1993	24
16	Neocortical concentrations of neuropeptides in senile dementia of the alzheimer and lewy body type: Comparison with parkinson's disease and severity correlations Biological Psychiatry ·A. Leake, Elaine K. Perry, Robert H. Perry, Sabiha Jabeen, Andrew Fairbairn, Ian G. McKeith, I. Nicol Ferrier	1991	26
17	Topography, Extent, and Clinical Relevance of Neurochemical Deficits in Dementia of Lewy Body Type, Parkinson's Disease, and Alzheimer's Disease Annals of the New York Academy of Sciences ·Elaine K. Perry, Ian G. McKeith, Paul M. Thompson, Elizabeth Marshall, Janet Kerwin, Sabiha Jabeen, J.A. Edwardson, Paul G. Ince, G. Blessed, D. Irving, Robert H. Perry	1991	107
18	Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression Biological Psychiatry ·A. Leake, Elaine K. Perry, Robert H. Perry, Andrew Fairbairn, I. Nicol Ferrier	1990	39
19	Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease BMJ ·A.J. Cross, Timothy J. Crow, Elaine K. Perry, Robert H. Perry, G. Blessed, B.E. Tomlinson	1981	211
20	Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ ·Elaine K. Perry, B. E. Tomlinson, G. Blessed, K. Bergmann, Peter H. Gibson, Robert H. Perry Hit paper breakdown →	1978	1620

About Robert H. Perry

Robert H. Perry is a scholar working on Cellular and Molecular Neuroscience, Pharmacology, Neurology, Neurology and Physiology, having authored 155 papers that have together received 15.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (48 papers), Cholinesterase and Neurodegenerative Diseases (42 papers), Neuroscience and Neuropharmacology Research (36 papers), Nicotinic Acetylcholine Receptors Study (33 papers), Parkinson's Disease Mechanisms and Treatments (29 papers), Receptor Mechanisms and Signaling (15 papers), Dementia and Cognitive Impairment Research (15 papers) and Memory and Neural Mechanisms (11 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (4.7k citations), Neurology (3.7k citations), Neurology (1.9k citations), Pharmacology (3.5k citations) and Physiology (4.9k citations). Robert H. Perry has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Elaine K. Perry, Andrew Fairbairn, G. Blessed, B.E. Tomlinson, Peter H. Gibson, Ian G. McKeith, Garry Blessed, Evelyn Jaros, B. E. Tomlinson and J.A. Court. Their work appears in journals such as Journal of the Neurological Sciences, Journal of Neurochemistry, Neurobiology of Aging, Alzheimer Disease & Associated Disorders and Acta Neuropathologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact